Guangzhou Development Zone added the world's Fortune 500 investment project Sai Mofei to fly to the Guangdong -Hong Kong -Macao Greater Bay Area base and settle down

Calligraphy Conferry, Correspondent of the Statue of the Base of the Guangdong -Hong Kong -Macao Greater Bay Area base

Text/Picture Yangcheng Evening News all -media reporter Liu Zhuonan correspondent Fan Minling Jiao Yanjuan Li Jingjing

On September 20th, the world's largest scientific analysis instrument manufacturer Saimo Fei Fei Shier Technology (hereinafter referred to as "Semo Fei") signed a cooperation agreement with the Guangzhou Economic and Technological Development Zone Management Committee, announcing that it will invest in the establishment of Simo in Guangzhou Development Zone Feishi Technology's Guangdong -Hong Kong -Macao Greater Bay Area base is expected to be completed and put into operation in 2023.

Simerfei plans to invest in the newly -built Guangdong -Hong Kong -Macao Greater Bay Area base, located at the China -Singapore Guangzhou Knowledge City International Biomedical Innovation Center, covering an area of ​​about 16,000 square meters. base. The completion of the Guangdong -Hong Kong -Macao Greater Bay Area Base will make full use of Saimo's cutting -edge technical advantages in the scientific service field, and produces high value -added products including high -end laboratory equipment, analysis instruments and laboratory consumables.

Feng Shihan, President of China, said that the Guangdong -Hong Kong -Macao Greater Bay Area is an important area for the Chinese biopharmaceutical industry, and it is also a key area for the construction operation of the "Fourteenth Five -Year Plan" Biological Economic Development Plan. one. Saimo's investment in the construction of the Guangdong -Hong Kong -Macao Greater Bay Area base will adhere to the localization development strategy of Saimo's "rooting China and serve China", further expand the layout of the localization development of Semo Fei, and continue to empower the ecological construction of regional industrial industries.

At present, Nine factories have been operated in Shanghai, Beijing, Suzhou, and Guangzhou, and 5 application development centers and demonstration laboratories have been established across the country.

At present, the Guangzhou Development Zone, as the core area of ​​the development of the biomedical industry in Guangzhou, has been built into a high -end development platform for Guangzhou International Bioscving, Guangzhou Science City, and Zhongxin Guangzhou Intellectual City to form research and development, trial, production, production, and production. Full industrial ecological chain. The signing of Semofei Guangdong -Hong Kong -Macao Greater Bay Area base project will further help the biopharmaceutical industry ecosystem of Guangzhou Development Zone to become bigger and stronger.

At present, the Guangzhou Development Zone has gathered more than 3,000 biomedical companies, covering the full chain of R & D, production, and sales in the fields of drugs, equipment, reagents and other fields. The industry scale exceeded 170 billion yuan, ranking among the first echelons in the development of the national biomedical industry. International Biomedical Value Innovation Park, which is located in Zhongxin Guangzhou Intellectual City, Gather 40 industrialized leading projects including Kangfang Biological, Longsha Biology, Hengrui Pharmaceutical, Baiji Shenzhou, Nuochengjianhua, and the production of macromolecular biopharmaceutical fluid in construction The scale reaches 600,000 liters and is leading in China.

- END -